1 Stanley Druckenmiller Ascendis Pharma A/S Trades
Stanley Druckenmiller acquired 265 Thousand Ascendis Pharma A/S shares worth $42.2 Million. That's 1.21% of their equity portfolio (21st largest holding). The stake costed the investor $35.8 Million, netting the investor a gain of 18% so far.